Eiger BioPharma: 2Q Earnings Snapshot

August 6, 2020 GMT

PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $15.3 million in its second quarter.

The Palo Alto, California-based company said it had a loss of 60 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

Eiger BioPharma shares have dropped 26% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.96, a climb of 11% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR